AbCellera Biologics Inc. (ABCL) Net margin 2019–2025
AbCellera Biologics Inc. (ABCL) net profit margin by fiscal year — reported net income divided by reported revenue.
-194.9%FY2025 · since FY2019: -19.0% → -194.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -194.9% | +369.9 pp |
| FY2024 | -564.8% | -179.8 pp |
| FY2023 | -385.0% | -417.7 pp |
| FY2022 | 32.7% | -8.2 pp |
| FY2021 | 40.9% | -10.1 pp |
| FY2020 | 51.0% | +70.0 pp |
| FY2019 | -19.0% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice